...(Proscar),

Analyzing Finasteride Data, Neurourology and Urodynamics 14:619-624 (1995)

.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.

...Hytrin.

The study was supervised by H. Lepor, New York University. See the New York Times, August 25, 1995. See also H. Lepor, Proceedings of the American Urological Society, vol. 155 587a, May 1996 Supplement

.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.

...Cardura.

I use the brand names because there has been much controversy among the companies, Merck, Abbott, and Pfiser, that both make and study them and lay readers know these names well.

.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.

...Stoner.

E. Stoner, Urology 43 3 (284-290) 1994.

.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.

...data.

loc. cit.

.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.